Clinical Trials Logo

Gastric Antral Vascular Ectasia clinical trials

View clinical trials related to Gastric Antral Vascular Ectasia.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT06306963 Recruiting - Cirrhosis Clinical Trials

Prevalence of Gastric Motor Dysfunction and Upper GI Symptoms in Gastric Antral Vascular Ectasias

GAVE
Start date: March 22, 2024
Phase:
Study type: Observational

The researchers are trying to find out more about Gastric Antral Vascular Ectasia (GAVE). This is a condition that affects the blood vessels in the stomach, leading to their enlargement and possible bleeding. It can also cause symptoms such as abdominal pain and nausea. By participating in this study, you will help us learn how often these symptoms occur and how they relate to stomach functioning.

NCT ID: NCT05690750 Recruiting - Liver Cirrhosis Clinical Trials

Gastric Antral Vascular Ectasia in Patients With Cirrhosis: Risk-factors and Associations.

Start date: January 19, 2023
Phase:
Study type: Observational

We will evaluate all out-patients and in-patients with cirrhosis, who undergo upper gastrointestinal endoscopy (EGD) in the Department of Hepatology, Institute of Liver and Biliary Sciences (ILBS), for inclusion. Patients with cirrhosis, with age >18-years, who have characteristic findings of GAVE on endoscopy will be included in this study. Their clinical and biochemical features, and endoscopy findings will be compared with a gender and age-matched control group of cirrhosis without GAVE. This observational, case-control study will aim to define the predictors of GAVE in patients with cirrhosis.

NCT ID: NCT03525366 Recruiting - Clinical trials for Gastric Antral Vascular Ectasia

Prospective Evaluation Of Outcomes For Patients Undergoing Radiofrequency Ablation (RFA) Using HALO Ultra Device For Gastric Antral Vascular Ectasia (GAVE)

GAVE
Start date: August 2015
Phase:
Study type: Observational [Patient Registry]

The purpose: To determine the safety and efficacy of Radiofrequency Ablation (RFA) HALO Ultra system in patients with Gastric Antral Vascular Ectasia patient cohort (GAVE). Research design: This is a prospective observational study. Procedure Used: Radiofrequency Ablation Risks and potential benefits: There are no risks associated with this study as it is a retrospective chart review. Potential benefits include the knowledge gained from this study which may be of help to patients in the future. Importance of knowledge that may reasonably be expected to result The knowledge gained from this study may be of help to other patients in the future.